Concepedia
Statistics
Publications
3
Citations
97
H-Index
Active since
2020
Affiliations
Robert Bosch Hospital(Current)
University of Tübingen
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Alina Muenchow is an author at Robert Bosch Hospital specializing in molecular oncology, oncology, and proteasome inhibitors.
Publications per year
2020–2022
Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer et al. · Cancers · 2020 · 38 citations · Full text
Life Sciences, Cell Biology, Oncology +16
The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA
Sandra Weller, Astrid Toennießen, Benjamin Schaefer et al. · Cell Death Discovery · 2022 · 33 citations · Full text
Medicine, Oncology, Pharmacology +17
The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA
Alina Muenchow, Sandra K. Weller, Clemens Hinterleitner et al. · Cell Death and Disease · 2020 · 26 citations · Full text
Medicine, Oncology, Pharmacology +15
1–3 of 3